Another case of reversibility of visual-field defect induced by vigabatrin monotherapy: is young age a favorable factor?

被引:15
作者
Giordano, L [1 ]
Valseriati, D
Vignoli, A
Morescalchi, F
Gandolfo, E
机构
[1] Spedali Civili, Div Infantile Neuropsychiat, I-25125 Brescia, Italy
[2] San Paolo Hosp, Reg Ctr Epilepsy, Milan, Italy
[3] Univ Brescia, Spedali Civili, Eye Clin, Brescia, Italy
关键词
Vigabatrin; Favorable Factor; Vigabatrin Monotherapy;
D O I
10.1007/s100720070096
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:185 / 186
页数:2
相关论文
共 4 条
[1]   Severe persistent visual field constriction associated with vigabatrin [J].
Eke, T ;
Talbot, JF ;
Lawden, MC .
BRITISH MEDICAL JOURNAL, 1997, 314 (7075) :180-181
[2]   Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects [J].
Kälviäinen, R ;
Nousiainen, I ;
Mäntyjärvi, M ;
Nikoskelainen, E ;
Partanen, J ;
Partanen, K ;
Riekkinen, P .
NEUROLOGY, 1999, 53 (05) :922-926
[3]   Visual field defects associated with vigabatrin therapy [J].
Lawden, MC ;
Eke, T ;
Degg, C ;
Harding, GFA ;
Wild, JM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (06) :716-722
[4]   Reversibility of vigabatrin-induced visual-field defect [J].
Versino, M ;
Veggiotti, P .
LANCET, 1999, 354 (9177) :486-486